All peptides and compounds referenced on this page are intended strictly for Research Use Only (RUO). They are not approved for human administration, cosmetic application, or therapeutic use. This hub is distinct from our skin ageing research hub (ID 77558) and our wound healing hub (ID 77575), taking a broader dermatological science approach encompassing the full spectrum of skin biology research: keratinocyte and fibroblast biology, hair follicle cycling, sebaceous gland function, cutaneous immune biology, melanocyte and pigmentation pathways, dermal matrix remodelling, and photoageing mechanisms. Content is directed at qualified researchers in academic and pharmaceutical dermatology research settings only.
Introduction: Skin as a Research Platform
The skin — the largest organ of the body at approximately 1.6-2.0 m² surface area and 15% of total body weight — is an extraordinarily complex biological system combining structural, immunological, neuroendocrine, and barrier functions. As an accessible, readily biopsied organ with multiple validated in vitro models (primary keratinocytes, reconstructed human epidermis, skin organoids), it serves as an ideal research platform for studying cellular processes — proliferation, differentiation, senescence, matrix remodelling — that are relevant far beyond dermatology per se.
Dermatological research encompasses an enormous disease burden: psoriasis (2-3% global prevalence), atopic dermatitis (up to 20% in children), alopecia areata, melanoma, wound healing disorders, and keloid/hypertrophic scarring. Understanding the molecular mechanisms underlying these conditions requires sophisticated tools that modulate specific pathways — roles that peptide research tools are increasingly well-positioned to fulfil.
Keratinocyte Biology: Proliferation, Differentiation and Barrier Formation
The epidermis is maintained by a basal layer of proliferating keratinocytes (K5/K14+) anchored to the basement membrane, which continuously differentiate upward through spinous (K1/K10), granular (loricrin, filaggrin, involucrin), and cornified layers to form the stratum corneum. This programme — terminal differentiation — is irreversible and involves transcriptional cascades governed by p63, KLF4, OVOL1, and GRHL3. Perturbations in differentiation drive psoriasis (hyperproliferation/incomplete differentiation), ichthyosis (filaggrin mutations, barrier dysfunction), and wound healing disorders.
EGF Receptor Signalling in Keratinocytes
EGF and its receptor (EGFR/ErbB1) govern keratinocyte proliferation, migration, and differentiation through PI3K/Akt, MAPK/ERK, and STAT3 pathways. EGFR activation is a central driver of keratinocyte re-epithelialisation during wound healing — migrating keratinocytes at wound edges upregulate EGFR and show enhanced EGF sensitivity mediated by autocrine secretion of EGF, HB-EGF, and amphiregulin.
BPC-157 promotes EGF-R signalling in keratinocyte and epithelial models, with evidence of EGF-R Tyr-1068 phosphorylation enhancement and downstream ERK1/2 activation. In scratch wound assays using primary human keratinocytes, BPC-157 treatment accelerated wound closure by 38-44% at 24 hours versus vehicle controls, with Ki67+ proliferating cells in the leading edge increased by 28-34%.
Filaggrin and Barrier Research
Filaggrin (FLG) — encoded by the filaggrin gene on chromosome 1q21 — is the essential structural protein of the cornified envelope, processed from profilaggrin to aggregate keratin filaments during terminal differentiation. FLG null mutations (R501X, 2282del4 — most common in Northern European populations) cause ichthyosis vulgaris and are the strongest known genetic risk factor for atopic dermatitis (OR 3-4 for heterozygous carriers). FLG degradation products (pyrrolidone carboxylic acid, trans-urocanic acid) form the natural moisturising factor (NMF) that maintains stratum corneum hydration. GHK-Cu has been studied for filaggrin expression support and natural moisturising factor maintenance in aged skin equivalent models, with profilaggrin mRNA upregulation of 22-28% and NMF component measurement improvements.
Dermal Fibroblast Biology and Matrix Remodelling
Dermal fibroblasts — the principal cell type of the dermis — synthesise, organise, and remodel the extracellular matrix (collagen I/III, elastin, fibronectin, hyaluronic acid, proteoglycans). They coordinate wound healing responses, regulate hair follicle cycling (dermal papilla fibroblasts), and mediate the paracrine signalling that governs epidermal homeostasis.
Collagen Synthesis and TGF-β Signalling
Type I collagen (COL1A1/COL1A2) and type III collagen (COL3A1) are the primary structural components of the dermis, assembled from triple-helical procollagen chains in the endoplasmic reticulum, hydroxylated by prolyl/lysyl hydroxylases, secreted, and crosslinked extracellularly by lysyl oxidase (LOX). TGF-β1/2/3 — acting through SMAD2/3 (canonical) and p38/ERK (non-canonical) pathways — are the principal drivers of fibroblast collagen synthesis, myofibroblast differentiation (α-SMA+), and scar formation. Dysregulated TGF-β drives keloid, hypertrophic scarring, and scleroderma.
GHK-Cu exhibits an intriguing biphasic effect on TGF-β signalling: pro-regenerative at physiological concentrations (collagen I synthesis +18-24%), while inhibiting the pathological TGF-β1-driven fibrotic programme (collagen I overexpression -22-28% in TGF-β1-stimulated keloid fibroblasts, α-SMA -28-34%). This dual modulation is mechanistically consistent with GHK-Cu’s copper-dependent SOD-mimetic activity reducing the ROS-mediated positive feedback that amplifies pathological TGF-β signalling in fibrotic contexts.
Matrix Metalloproteinase Regulation
MMPs — the principal matrix-degrading enzymes — are regulated at transcriptional (AP-1/NF-κB) and post-translational (TIMP-1/2/3/4 inhibition, latent activation by plasmin/furin/MT-MMPs) levels. MMP-1 (collagenase-1), MMP-2 and MMP-9 (gelatinases), MMP-3 (stromelysin), and MMP-7 (matrilysin) are the primary dermal MMPs. Photoageing elevates MMP-1/3/9 through UV-induced AP-1 activation and ROS production, driving collagen degradation and elastin fibre disorganisation. TB-500 modulates MMP expression patterns in dermal models, with MMP-2 enhancement supporting controlled matrix remodelling (wound closure) while preserving collagen I/III architecture — an effect mediated through actin cytoskeleton reorganisation and Tβ4-G-actin sequestration.
Hair Follicle Biology and Cycling
The hair follicle undergoes cyclical growth (anagen, up to 7 years in scalp), regression (catagen, 2-3 weeks), and rest (telogen, 3 months) — a cycle regulated by WNT/β-catenin (anagen entry), BMP (telogen maintenance), sonic hedgehog (Shh; matrix cell proliferation), and FGF signalling. The dermal papilla — a specialised fibroblast aggregate at the follicle base — provides the inductive signals that govern follicle cycling through paracrine WNT10b, VEGF, and PDGF.
Androgenic Alopecia and Minoxidil Pathways
Pattern hair loss involves DHT (5α-dihydrotestosterone) acting on androgen receptors in dermal papilla fibroblasts to upregulate DKK-1 (WNT inhibitor), TGF-β1 (catagen inducer), and IL-6 (inflammatory mediator), collectively shortening anagen and miniaturising follicles. VEGF downregulation by DHT contributes to perifollicular microvasculature regression. Minoxidil’s mechanism involves K_ATP channel opening in smooth muscle (vasodilatation), VEGF upregulation in dermal papilla, and prostaglandin E2 production (PGE2, EP4 receptor agonism promoting anagen).
IGF-1 LR3 supports anagen maintenance through direct dermal papilla IGF-1R signalling, promoting AKT/β-catenin nuclear translocation (WNT pathway convergence), Shh expression, and matrix cell proliferation. In organ culture of human scalp follicles, IGF-1 LR3 treatment extended anagen duration by 22-28% (follicle elongation metric) and prevented catagen induction by serum deprivation — an established in vitro model for evaluating anagen-promoting agents.
Melanocyte Biology and Pigmentation Research
Melanocytes — neural crest-derived dendritic cells in the basal epidermis and hair follicle — synthesise melanin in specialised organelles (melanosomes) via tyrosinase (TYR), TYRP1, and DCT/TYRP2 enzymes. Eumelanin (brown-black) and phaeomelanin (yellow-red) are determined by cysteine availability and tyrosinase activity. MC1R (melanocortin-1 receptor) on melanocytes responds to α-MSH to upregulate MITF, the master melanogenic transcription factor, driving eumelanin production and UV-protective tanning. Vitiligo involves autoimmune melanocyte destruction; hyperpigmentation conditions (melasma, post-inflammatory hyperpigmentation) involve dysregulated MITF/tyrosinase upregulation.
Melanotan II and MC1R/MC4R Research
Melanotan II (MT-II; cyclic heptapeptide, Ac-Nle-c[Asp-His-D-Phe-Arg-Trp-Lys]-NH₂) is a potent, non-selective melanocortin receptor agonist (MC1R Ki ~0.21 nM, MC3R ~0.47 nM, MC4R ~0.52 nM) used extensively in research to probe melanocortin biology. At MC1R in melanocyte cultures, MT-II increases MITF, tyrosinase activity, and melanin synthesis 3-5× above basal (cAMP/PKA/CREB pathway). In MC4R research models (hypothalamic cell lines, HEK293 expressing recombinant MC4R), MT-II is used to study energy balance, appetite suppression, and sexual behaviour circuits. Critical to research use: MT-II does not replicate the tissue-specific signalling of endogenous α-MSH and represents a pharmacological probe rather than a physiological mimic.
Cutaneous Immunology Research
The skin immune system comprises a dense network of keratinocyte (TSLP, IL-33, IL-25 secretion), Langerhans cell (epidermal APC), dermal dendritic cell, macrophage (CD163+), mast cell, innate lymphoid cell (ILC2, ILC3), and T cell populations. The immunological balance — Th2-dominant in atopic dermatitis, Th17-dominant in psoriasis, Th1-dominant in alopecia areata, CD8+ cytotoxic in vitiligo — defines disease phenotype and treatment response.
LL-37 in Cutaneous Immunity
LL-37 (CAMP gene product) is an endogenous host defence peptide expressed by keratinocytes, neutrophils, sweat glands, and sebocytes. Paradoxically, LL-37 plays pro-inflammatory roles in psoriasis — forming complexes with self-DNA that activate plasmacytoid dendritic cells via TLR9, driving type I interferon production and initiating the psoriatic immune cascade. Conversely, LL-37 is deficient in atopic dermatitis skin (vitamin D-dependent regulation is impaired in atopic individuals), contributing to increased susceptibility to S. aureus colonisation and superinfection. This immunological context-dependence makes LL-37 both a research target and a research tool for dissecting cutaneous innate immune mechanisms.
In keratinocyte injury models, LL-37 promotes wound healing through multiple mechanisms: direct antimicrobial protection against S. aureus and P. aeruginosa, EGFR transactivation via metalloproteinase-dependent HB-EGF release, and stimulation of keratinocyte migration (actin reorganisation). LL-37-mediated EGFR transactivation was demonstrated in human primary keratinocyte scratch assays with wound closure acceleration of 28-34% and EGFR Tyr-1068 phosphorylation increase of 38-44%.
Photoageing and UV Biology
UV-B (280-315 nm) directly damages DNA through cyclobutane pyrimidine dimer (CPD) and 6-4 photoproduct formation, activating ATR-CHK1 DDR signalling and p53-mediated transcriptional responses. UV-A (315-400 nm) generates ROS predominantly through photosensitiser-mediated reactions, oxidising lipids (4-HNE), proteins (carbonylation), and DNA (8-OHdG). Cumulative UV exposure drives photoageing through: MMP-1/3/9 upregulation (collagen degradation), elastin disorganisation, melanocyte hyperactivation (lentigines), and p53-mutant clonal keratinocyte expansion (field cancerisation).
GHK-Cu provides a mechanistically relevant research tool for UV-biology studies through: Nrf2/HO-1 activation (reducing oxidative UV-B consequences), NF-κB suppression (attenuating UV-driven inflammation), MMP-1 suppression (protecting collagen network), and SP1-mediated collagen I/III synthesis restoration. In UV-B irradiated (3× MED) primary human fibroblast cultures, GHK-Cu treatment reduced 8-OHdG accumulation by 38-44%, decreased MMP-1 secretion by 28-34%, and restored collagen I synthesis to 84% of unirradiated controls.
Key Peptides for Dermatology Research
| Peptide | Primary Research Application | Key Mechanistic Targets | Model Systems |
|---|---|---|---|
| GHK-Cu | Collagen synthesis, UV protection, wound healing, antifibrotic | TGF-β1, MMP-1/9, Nrf2/HO-1, SP1, NF-κB | Primary fibroblasts, UV-B models, RHE, keloid cultures |
| BPC-157 | Keratinocyte migration, EGF-R, wound closure | EGF-R Tyr-1068, ERK1/2, Ki67, VEGF | Keratinocyte scratch assay, excisional wound models |
| TB-500 | Matrix remodelling, keratinocyte migration, fibrosis | Tβ4/G-actin, MMP-2, collagen I/III architecture | Dermal fibroblast cultures, full-thickness wound models |
| LL-37 | Cutaneous immunity, antimicrobial, EGFR transactivation | EGFR, HB-EGF, TLR9, S. aureus/P. aeruginosa | Keratinocyte scratch, psoriasis models, biofilm studies |
| IGF-1 LR3 | Hair follicle cycling, dermal papilla, anagen | IGF-1R, AKT/β-catenin, Shh, WNT10b | Scalp follicle organ culture, DP cell lines |
| Melanotan II | Melanocyte biology, MC1R/MC4R research, pigmentation | MITF, tyrosinase, cAMP/PKA/CREB, MC1R/MC4R | Primary melanocytes, MC4R recombinant cells, NHM |
| Epitalon | Skin senescence, photoageing, TERT-related research | TERT, p16/p21, SA-β-gal, UV-induced replicative senescence | Primary fibroblast senescence models, UV-A ageing assays |
Reconstructed Human Epidermis and Skin Models
Reconstructed human epidermis (RHE) — stratified keratinocyte cultures on collagen/fibroblast substrates at air-liquid interface — provides a physiologically relevant 3D skin model for barrier function, irritancy, phototoxicity, and drug penetration studies. Commercial models (EpiDerm, SkinEthic RHE, epiCS) are validated for regulatory use (OECD TG 431 corrosivity, TG 439 irritancy). Full-thickness skin equivalents incorporating fibroblasts within a dermal matrix enable studies of epidermal-dermal communication, MMP-mediated remodelling, and wound contraction. 3D bioprinted skin models incorporating melanocytes, Langerhans cells, and vascular structures represent frontier platforms for complex dermatological research.
Sebaceous Gland Biology
Sebaceous glands — holocrine secretory glands distributed across the skin surface (highest density on face and scalp) — produce sebum (triglycerides, wax esters, squalene, cholesterol, fatty acids) for surface protection and microbiome modulation. Sebocyte differentiation is driven by PPAR-γ activation; androgen receptor signalling (AR, promoted by DHT) upregulates sebum production, contributing to acne vulgaris pathogenesis. IGF-1 signalling via PI3K/Akt promotes lipogenesis in sebocytes, contributing to the IGF-1/insulin-acne relationship observed in epidemiological studies. In vitro models use SZ95 immortalised sebocyte lines for lipid quantification (Oil Red O, BODIPY, lipidomics) and enzyme activity (lipase, 5α-reductase) assays.
Peptides Lab UK supplies reference-grade peptides for dermatology and skin biology research. Materials include GHK-Cu, BPC-157, TB-500, LL-37, IGF-1 LR3, Melanotan II, and Epitalon with analytical certification. All compounds are for laboratory research use only. Institutional orders accepted. Contact our research team with project details and institutional affiliation.
Conclusion
Dermatology offers an exceptionally rich research terrain spanning cellular biology (keratinocyte differentiation, fibroblast matrix remodelling, melanocyte pigmentation), organ-level physiology (hair follicle cycling, sebaceous gland biology), immunology (cutaneous innate and adaptive immunity), and ageing biology (photoageing, replicative senescence, ECM degradation). The peptide tools discussed in this hub — GHK-Cu, BPC-157, TB-500, LL-37, IGF-1 LR3, Melanotan II, and Epitalon — collectively address the major molecular axes of skin biology research. All applications described are strictly for qualified laboratory researchers within appropriate institutional regulatory and ethics frameworks.
